OCULAR THERAPEUTIX INC (OCUL) Top Institutional Shareholders

OCULAR THERAPEUTIX INC (OCUL) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.70B in OCUL holdings during the latest filing period.

Fmr Llc is currently the largest disclosed institutional shareholder of OCUL tracked by InsiderSet, reporting ownership valued at approximately $276.58M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $314.78M, representing an estimated gain of +13.81% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 64% of the total disclosed OCUL value among the investors covered in this analysis. Major shareholders include Fmr Llc, Deep Track Capital, Lp, Blackrock, Inc., and several other long-term asset managers with concentrated positions in OCULAR THERAPEUTIX INC (OCUL).

This page ranks the largest institutional OCUL shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

263

Total Reported Value

$1.70B

Largest Holder

Fmr Llc

Largest Position

$276.58M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

137

Funds Exiting Positions

0

Page 1 of 6
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Fmr Llc0.01%32,653,764$276,577,378$314,782,285+$38,204,907+13.81%
Deep Track Capital, Lp3.44%19,686,282$166,742,809$189,775,758+$23,032,949+13.81%
Blackrock, Inc.0.00%16,132,931$136,645,927$155,521,455+$18,875,528+13.81%
Avoro Capital Advisors Llc1.03%12,315,000$104,308,050$118,716,600+$14,408,550+13.81%
Summer Road Llc70.84%11,879,825$100,622,118$114,521,513+$13,899,395+13.81%
Venrock Adviser, Llc3.27%10,346,926$87,638,463$99,744,367+$12,105,904+13.81%
Vanguard Capital Management Llc0.00%8,719,039$73,850,260$84,051,536+$10,201,276+13.81%
Alliancebernstein L.P.0.02%4,129,687$50,134,400$39,810,183-$10,324,217-20.59%
Point72 Asset Management, L.P.0.08%5,534,985$46,881,323$53,357,255+$6,475,932+13.81%
State Street Corp0.00%4,708,419$39,880,309$45,389,159+$5,508,850+13.81%
Geode Capital Management, Llc0.00%4,529,185$38,368,500$43,661,343+$5,292,843+13.79%
Logos Global Management Lp1.68%3,850,000$32,609,500$37,114,000+$4,504,500+13.81%
Octagon Capital Advisors Lp2.97%3,166,600$26,821,102$30,526,024+$3,704,922+13.81%
Balyasny Asset Management L.P.0.04%2,692,622$22,806,508$25,956,876+$3,150,368+13.81%
Commodore Capital Lp1.26%2,575,000$21,810,250$24,823,000+$3,012,750+13.81%
Deltec Asset Management Llc3.64%2,340,620$19,825,051$22,563,577+$2,738,526+13.81%
Two Sigma Investments, Lp0.01%1,830,159$15,501,447$17,642,733+$2,141,286+13.81%
Woodline Partners Lp0.05%1,667,609$14,124,648$16,075,751+$1,951,103+13.81%
Tcg Crossover Management, Llc0.40%1,647,752$13,956,459$15,884,329+$1,927,870+13.81%
Vanguard Portfolio Management Llc0.00%1,594,666$13,506,821$15,372,580+$1,865,759+13.81%
Invesco Ltd.0.00%1,536,779$13,016,517$14,814,550+$1,798,033+13.81%
Northern Trust Corp0.00%1,525,626$12,922,052$14,707,035+$1,784,983+13.81%
Ubs Group Ag0.00%1,520,631$12,879,744$14,658,883+$1,779,139+13.81%
Defilade Capital Management, L.P.1.77%1,487,645$12,600,353$14,340,898+$1,740,545+13.81%
Charles Schwab Investment Management Inc0.00%1,461,177$12,376,169$14,085,746+$1,709,577+13.81%
Morgan Stanley0.00%1,280,119$10,842,614$12,340,347+$1,497,733+13.81%
Vanguard Fiduciary Trust Co0.00%1,245,024$10,545,353$12,002,031+$1,456,678+13.81%
Renaissance Technologies LLCJim Simons0.02%1,147,982$9,723,408$11,066,546+$1,343,138+13.81%
Goldman Sachs Group Inc0.00%1,110,366$9,404,800$10,703,928+$1,299,128+13.81%
Squarepoint Ops Llc0.02%980,757$8,307,012$9,454,497+$1,147,485+13.81%
Sio Capital Management, Llc1.18%968,597$8,204,017$9,337,275+$1,133,258+13.81%
Candriam S.C.A.0.04%949,216$8,039,860$9,150,442+$1,110,582+13.81%
Artisan Partners Limited Partnership0.01%902,931$7,647,826$8,704,255+$1,056,429+13.81%
Readystate Asset Management Lp0.44%883,621$7,484,270$8,518,106+$1,033,836+13.81%
Empire Life Investments Inc.0.45%884,297$7,366,194$8,524,623+$1,158,429+15.73%
Raymond James Financial Inc0.00%859,485$7,279,838$8,285,435+$1,005,597+13.81%
Jane Street Group, Llc0.01%804,589$6,814,868$7,756,238+$941,370+13.81%
Cetera Investment Advisers0.01%764,615$6,476,285$7,370,889+$894,604+13.81%
Walleye Capital Llc0.04%741,142$6,277,473$7,144,609+$867,136+13.81%
Marshall Wace, Llp0.01%740,803$6,274,601$7,141,341+$866,740+13.81%
Peregrine Capital Management Llc0.23%720,462$6,102,313$6,945,254+$842,941+13.81%
Dimensional Fund Advisors Lp0.00%649,756$5,491,045$6,263,648+$772,603+14.07%
Citadel Advisors Llc0.00%635,922$5,386,259$6,130,288+$744,029+13.81%
Deutsche Bank Ag\0.00%631,741$5,350,846$6,089,983+$739,137+13.81%
Tudor Investment Corp Et Al0.03%614,378$5,203,782$5,922,604+$718,822+13.81%
Knoll Capital Management, Llc2.82%600,400$5,085,388$5,787,856+$702,468+13.81%
Opaleye Management Inc.0.67%600,000$5,082,000$5,784,000+$702,000+13.81%
Acuta Capital Partners, Llc3.57%592,108$5,015,155$5,707,921+$692,766+13.81%
Second Line Capital, Llc0.94%528,290$4,950,077$5,092,716+$142,639+2.88%
Aberdeen Group Plc0.01%558,380$4,729,479$5,382,783+$653,304+13.81%

Frequently asked questions about OCUL

  • Who owns the most OCUL stock?

    The largest holders of OCUL are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for OCULAR THERAPEUTIX INC (OCUL).

  • Is OCUL widely held by superinvestors?

    Many widely followed stocks like OCUL appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly OCUL is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.